NEI Research News

A combination of anti-HIV drugs appears to help rejuvenate the immune systems of people with AIDS and prevent progression of cytomegalovirus (CMV) retinitis, a potentially blinding AIDS-related eye complication.

Researchers at the National Institutes of Health (NIH) have discovered a substance that allows people with uveitis, a potentially blinding eye disease, to stop or reduce the need for powerful drugs.

A combination of two antiviral drugs is more effective than either drug alone for controlling recurrences of a blinding eye infection common in people with AIDS, according to new clinical trial results from a federally-sponsored study.

Briefly freezing a portion of the eye’s surface can protect many premature infants against blindness from retinopathy of prematurity (ROP), a disease that causes visual loss in 2,600 infants in the United States annually.